CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) Sees Large Increase in Short Interest

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOYGet Free Report) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totaling 5,000 shares, a growth of 163.2% from the August 31st total of 1,900 shares. Based on an average trading volume of 16,600 shares, the short-interest ratio is currently 0.3 days. Based on an average trading volume of 16,600 shares, the short-interest ratio is currently 0.3 days.

Analyst Ratings Changes

A number of brokerages have weighed in on CHEOY. Citigroup lowered CochLear to a “neutral” rating in a report on Thursday, September 18th. UBS Group raised CochLear from a “hold” rating to a “strong-buy” rating in a report on Wednesday, June 18th. Finally, Zacks Research raised CochLear to a “hold” rating in a report on Monday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy”.

Get Our Latest Stock Analysis on CHEOY

CochLear Stock Performance

Shares of CHEOY stock opened at $93.67 on Friday. CochLear has a fifty-two week low of $74.76 and a fifty-two week high of $105.60. The business has a fifty day simple moving average of $98.46 and a 200-day simple moving average of $92.41.

CochLear Dividend Announcement

The business also recently declared a dividend, which will be paid on Tuesday, October 28th. Investors of record on Monday, September 22nd will be issued a $0.1045 dividend. The ex-dividend date of this dividend is Friday, September 19th. This represents a dividend yield of 122.0%.

About CochLear

(Get Free Report)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Read More

Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.